These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 27340673)
21. Single vs multiallergen sublingual immunotherapy in the polysensitized patient: a pilot study. Ortiz AS; McMains KC; Laury AM Int Forum Allergy Rhinol; 2018 Apr; 8(4):490-494. PubMed ID: 29377605 [TBL] [Abstract][Full Text] [Related]
22. Sublingual Immunotherapy for Other Indications: Venom Large Local, Latex, Atopic Dermatitis, and Food. Smith DM; Freeman TM Immunol Allergy Clin North Am; 2020 Feb; 40(1):41-57. PubMed ID: 31761120 [TBL] [Abstract][Full Text] [Related]
23. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study From Kashmir. Baba SM; Rasool R; Gull A; Qureshi TA; Beigh AH; Qadri Q; Shah ZA Front Immunol; 2021; 12():723814. PubMed ID: 34721385 [TBL] [Abstract][Full Text] [Related]
26. Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite? Kiykim A; Mumcu G; Ogulur I; Karakoc-Aydiner E; Direskeneli H; Baris S; Cagan H; Ozen A Int Arch Allergy Immunol; 2017; 174(1):52-56. PubMed ID: 28950285 [TBL] [Abstract][Full Text] [Related]
27. New applications for sublingual immunotherapy in allergy. Incorvaia C; Mauro M; Cappelletti T; Pravettoni C; Leo G; Riario-Sforza GG Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):113-7. PubMed ID: 19519587 [TBL] [Abstract][Full Text] [Related]
29. Local immunotherapy in allergy. Morris DL; Kroker GF; Sabnis VK; Morris MS Chem Immunol Allergy; 2003; 82():1-10. PubMed ID: 12947987 [TBL] [Abstract][Full Text] [Related]
30. Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study. Bousquet J; Sousa-Pinto B; Shamji MH; Anto JM; Klimek L; Canonica GW; Czarlewski W; Devillier P; Haahtela T; Laune D; Mullol J; Brussino L; Cecchi L; Kvedariene V; Morais-Almeida M; Mösges R; Niedoszytko M; Papadopoulos NG; Patella V; Pham-Thi N; Samolinski B; Taborda-Barata L; Toppila-Salmi S; Sastre J; Valiulis A; Ventura MT; Jutel M; Kuna P; Valovirta E; Zuberbier T; Fonseca JA; Pfaar O Clin Exp Allergy; 2023 Aug; 53(8):854-861. PubMed ID: 37070243 [No Abstract] [Full Text] [Related]
31. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials. Tao L; Shi B; Shi G; Wan H Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881 [TBL] [Abstract][Full Text] [Related]
32. The current state of food allergy therapeutics. Chen M; Land M Hum Vaccin Immunother; 2017 Oct; 13(10):2434-2442. PubMed ID: 28846472 [TBL] [Abstract][Full Text] [Related]
33. [New administration routes for immunotherapy]. Martorell Aragonés A Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377 [TBL] [Abstract][Full Text] [Related]
34. How important is proper dosing for subcutaneous and sublingual allergy immunotherapy? Nelson HS Allergy Asthma Proc; 2021 Sep; 42(5):368-377. PubMed ID: 34474706 [No Abstract] [Full Text] [Related]
35. The influence of sublingual immunotherapy on several parameters of immunological response in children suffering from atopic asthma and allergic rhinitis depending on asthma features. Ciepiela O; Zawadzka-Krajewska A; Kotuła I; Demkow U Pneumonol Alergol Pol; 2014; 82(6):503-10. PubMed ID: 25339560 [TBL] [Abstract][Full Text] [Related]
37. One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis. Sayed KM; Kamel AG; Ali AH Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1989-1996. PubMed ID: 31209565 [TBL] [Abstract][Full Text] [Related]
38. Selection of patients for sublingual versus subcutaneous immunotherapy. Larenas Linnemann DE; Blaiss MS Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418 [TBL] [Abstract][Full Text] [Related]
39. [Practice patterns in Mexican allergologists about specific immunotherapy with allergens]. Larenas Linnemann D; Guidos Fogelbach GA; Arias Cruz A Rev Alerg Mex; 2008; 55(2):53-61. PubMed ID: 19058482 [TBL] [Abstract][Full Text] [Related]
40. Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United States. Epstein TG; Calabria C; Cox LS; Dreborg S J Allergy Clin Immunol Pract; 2017; 5(1):34-40.e2. PubMed ID: 27815065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]